The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results